Drug that delays onset of type 1 diabetes gets approval in US
New ScientistJUL 2022
"Smart" insulin could dramatically improve the lives of people with type 1 diabetes. Reducing the need for multiple daily injections to just once a week, it would free them from constant glucose monitoring, easing both physical and mental burdens. The technology aims to maintain stable blood sugar levels more effectively than current treatments, potentially reducing long-term health complications. It promises to simplify diabetes management, offering patients greater freedom and peace of mind in their daily lives.
While new "smart insulins" show promise, accessibility remains a critical issue. Despite insulin's discoverers intending it to be widely available, it has become prohibitively expensive for many patients. The problem, therefore, isn't about creating better insulins alone but ensuring affordable access to existing treatments. Strategies like discontinuing older, cheaper versions and blocking competition have kept prices high.
There is a 10% chance of an FDA-approved cure for Type 1 diabetes before Jan. 1, 2032, according to the Metaculus prediction community.